Chaoju Eye Care Holdings Limited (2219.HK)
- Previous Close
2.740 - Open
2.740 - Bid 2.780 x --
- Ask 2.790 x --
- Day's Range
2.720 - 2.840 - 52 Week Range
2.400 - 4.020 - Volume
763,000 - Avg. Volume
1,377,946 - Market Cap (intraday)
1.932B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
9.10 - EPS (TTM)
0.300 - Earnings Date Mar 26, 2025
- Forward Dividend & Yield 0.47 (17.25%)
- Ex-Dividend Date Jun 10, 2025
- 1y Target Est
5.16
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases. In addition, it sells eyewear, equipment, and optical products. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.
www.chaojueye.com2,608
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2219.HK
View MorePerformance Overview: 2219.HK
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2219.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2219.HK
View MoreValuation Measures
Market Cap
1.93B
Enterprise Value
511.63M
Trailing P/E
9.08
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.25
Price/Book (mrq)
0.78
Enterprise Value/Revenue
0.34
Enterprise Value/EBITDA
1.14
Financial Highlights
Profitability and Income Statement
Profit Margin
13.88%
Return on Assets (ttm)
5.32%
Return on Equity (ttm)
7.92%
Revenue (ttm)
1.41B
Net Income Avi to Common (ttm)
195.08M
Diluted EPS (ttm)
0.300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.53B
Total Debt/Equity (mrq)
9.37%
Levered Free Cash Flow (ttm)
311.88M